Progressive Familial Intrahepatic Cholestasis 1 - 9 Studies Found
No longer available |
: Buphenyl Therapy for Byler's Disease : Byler Disease : 2013-02-04 : Drug: Buphenyl |
No longer available |
: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease : Byler Disease : 2013-09-20 : Drug: Glycerol phenylbutyrate Other Name: RAVICTI |
Temporarily not available |
: Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease : Byler Disease : 2014-03-19 : Drug: RAVICTI open label expanded access protocol of titrated dosing regimen of RAVICTI for up to 60 wee |
Active, not recruiting |
: Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis : Progressive Familial Intrahepatic Cholestasis (PFIC) : 2014-02-05 : Drug: LUM001 LUM001 oral dose |
Completed |
: Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease :
|
Completed |
: An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects :
|
Completed |
: A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384 :
|
Completed |
: Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases : Hepatobiliary Diseases : 2010-08-31 |
Recruiting |
: Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC) :
|